Fri, 17 Apr 2015 | BUSINESS SALE
GE Capital, a specialist corporate finance group, is up for sale by its parent company General Electric.
General Electric has announced that the company decided upon a sale in order to allow the broader business to “focus on continued investment and growth in its industrial businesses”.
As a result, GE Capital is on the market. Included in the sale will be the company's commercial lending and leasing businesses, as well as healthcare and energy finance and investment divisions and assets.
A statement from GE Capital announced the business for sale. The firm went on to state: “Here in the UK, GE Capital is open for business. We remain fully committed to our customers and are focused on delivering for each and every one.
“We anticipate being able to sell our businesses to buyers who are fully committed to and invested in the financial services industry and can offer a good environment for growth.”
The first stage of the sale will involve the sale of the bulk of GE Capital Real Estate assets. It is thought that these assets have a collective value of some $26.5 billion (£17.6 billion). As yet it is unclear how these assets will be divided for sale.
Jeff Immelt, General Electric's chairman and CEO, noted in a statement that the company expects strong returns, adding that this is “a good time to move” on the sale in the wake of other recent business exists and IPOs which have “bolstered” General Electric's confidence that GE Capital will be more valuable under new ownership.
“The market is strong for the businesses we will sell, and I am confident they will thrive elsewhere,” he remarked.
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.